[PR1] Determinants of Orphan Drug Prices in France: Regression Analysis
2015 Value in Health
Korchagina, D. | Vataire, A. | Toumi, M. | Falissard, B. | Aballéa, S. |
No specific market access process has been developed for orphan drugs (ODs) in France, but there is an unspoken will to support these medicines. Pricing process of ODs is unclear, and many of them became blockbusters despite the small size of the targeted population. The aim of the study is to identify the main drivers of ODs prices in France.